VIVIMEDLAB Quarterly Results, Profit & Loss, Balance Sheet (VIVIMEDLAB)

VIVIMEDLAB quarterly results and annual financials: sales, operating profit, OPM, net profit, EPS, balance sheet, cash flow and ratios like ROCE, with YoY and QoQ growth.

  • VIVIMEDLAB Financials
  • VIVIMEDLAB Shareholding Pattern
  • VIVIMEDLAB Earnings Documents
  • VIVIMEDLAB Announcements
  • VIVIMEDLAB Corporate Actions
  • VIVIMEDLAB Bulk, Block & Insider Deals
  • VIVIMEDLAB Delivery Data
  • VIVIMEDLAB Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Vivimed Labs Ltd (VIVIMEDLAB) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow

Vivimed Labs Ltd reported sales of ₹12 Cr, operating profit of ₹-140 Cr (OPM -1,169%) and net profit of ₹-147 Cr for the quarter ended Mar 2026. Figures in ₹ crore, consolidated where available.

VIVIMEDLAB quarterly results (₹ Cr)
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales2925372621211612
YoY Sales growth-17-26-12-34-27-17-56-53
Expenses40253528222227152
Operating Profit-11-11-20-1-11-140
OPM-37%-2.6%2.9%-10%-1.3%-4.6%-68%-1,169%
Other Income00040006
Interest00021211
Depreciation447655512
Profit before tax-15-5-6-5-5-7-17-147
Tax0%0%0%2%0%0%0%0%
Net Profit-15-5-6-6-5-7-17-147
EPS in Rs-1.84-0.62-0.72-0.68-0.66-0.88-2-17.74
VIVIMEDLAB profit & loss, annual (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2371871491167084
Sales growth-72-21-20-22-40-
Expenses24537418212922298
Operating Profit-8-187-33-13-152-15
OPM-3.3%-100%-22%-11%-218%-18%
Other Income1110465
Interest40363345
Depreciation1810820202620
Profit before tax-65-331-46-32-176-35
Tax4%-1%-1%0%0%-
Net Profit-68-329-45-32-176-35
EPS in Rs-8.16-39.62-5.48-3.85-21.28-4.22
Dividend Payout0%0%0%0%0%-
VIVIMEDLAB balance sheet (₹ Cr)
MetricMar 2023Mar 2024Mar 2025Sep 2025Mar 2026
Equity Capital1717171717
Reserves23-22-52-65-227
Borrowings379377376384397
Other Liabilities658579580588567
Total Liabilities1,076950921924753
Fixed Assets436418408393386
CWIP2121172118
Investments199168168168181
Other Assets421343328342170
Total Assets1,076950921924753
VIVIMEDLAB cash flows (₹ Cr)
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity2835-24-28
Cash from Investing Activity-16-528-5-1
Cash from Financing Activity-10-34-65-6
Net Cash Flow1-3-2-11
Free Cash Flow1130-26-67
CFO/OP-352%-19%73%13%-5%
CFO/EBITDAShare of operating profit converting into cash: CFO (before tax) / Operating Profit-352-197313-5
VIVIMEDLAB ratios
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days134145203233236
Inventory Days57321632735863
Days Payable10074225240263
Cash Conversion Cycle60728630535136
Working Capital Days195-15-171-255-1,468
ROCE-3%-52%-11%-8%-65%
  • VIVIMEDLAB Shareholding Pattern
  • VIVIMEDLAB Earnings Concalls
  • VIVIMEDLAB Growth Catalysts
  • VIVIMEDLAB Corporate Actions
  • VIVIMEDLAB Announcements
  • VIVIMEDLAB Results & Documents
  • VIVIMEDLAB Bulk & Block Deals
  • VIVIMEDLAB Delivery Data